<!DOCTYPE html
  PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:n1="urn:hl7-org:v3">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
   
      <title>Oncology Breast Cancer:  Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/Progesterone Receptor (ER/PR) Positive Breast
         Cancer
      </title><style type="text/css">
body {
	color: rgb(26, 26, 26);
	background-color: rgb(255,255,255);
	font-family: Verdana, Tahoma, sans-serif;
	font-size: 11px;
}

a {
	color: rgb(0, 0, 255);
	background-color: rgb(255,255,255);
}

h1 {
	font-size: 12pt;
	font-weight: bold;
}

h2 {
	font-size: 11pt;
	font-weight: bold;
}

h3 {
	font-size: 10pt;
	font-weight: bold;
}

h4 {
	font-size: 8pt;
	font-weight: bold;
}

div {
	width: 80%;
}

table {
	line-height: 10pt;
	width: 80%;
}

tr {
	background-color: rgb(224,224,224);
}

td {
	padding: 0.1cm 0.2cm;
	vertical-align: top;
}

.h1center {
	font-size: 12pt;
	font-weight: bold;
	text-align: center;
	width: 80%;
}

.header_table{
	border: 1pt inset rgb(0,0,0);
}

.narr_table {
	width: 100%;
}

.narr_tr {
	background-color: rgb(225,225,225);
}
pre {
 overflow: auto; /* Use horizontal scroller if needed; for Firefox 2, not needed in Firefox 3 */
 white-space: pre-wrap; /* css-3 */
 white-space: -moz-pre-wrap !important; /* Mozilla, since 1999 */
 white-space: -pre-wrap; /* Opera 4-6 */
 white-space: -o-pre-wrap; /* Opera 7 */
 word-wrap: break-word; /* Internet Explorer 5.5+ */
 font-family: Verdana, Tahoma, sans-serif;
 font-size: 11px;
 text-align:left;
 margin: 0px 0px 0px 0px;
 padding:0px 0px 0px 0px;
}
.narr_th {
	background-color: rgb(201,201,201);
}

.td_label{
	font-weight: bold;
	color: white;
}
	</style></head>
   <body>
      <h1 class="h1center">Oncology Breast Cancer:  Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/Progesterone Receptor (ER/PR) Positive Breast
         Cancer (NQF 0387)
      </h1>
      <table class="header_table">
         <tbody>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Name</span></td>
               <td width="30%">Oncology Breast Cancer:  Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/Progesterone Receptor (ER/PR) Positive Breast
                  Cancer
               </td>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Id</span></td>
               <td width="30%"> 73EC4A14-B49B-4793-8469-37A4BA1967D9</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Version number</span></td>
               <td width="30%">1</td>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Set Id</span></td>
               <td width="30%"> 5A6D5F80-37B5-45A2-96A4-8B8FFC3229FF</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Available Date</span></td>
               <td width="30%"> No information </td>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measurement Period</span></td>
               <td>January 1, 20xx  through December 31, 20xx </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Steward</span></td>
               <td width="80%" colspan="3">American Medical Association - Physician Consortium for Performance Improvement</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Endorsed by</span></td>
               <td width="80%" colspan="3">National Quality Forum</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Description</span></td>
               <td width="80%" colspan="3">Percentage of female patients aged 18 years and older with Stage IC through IIIC, ER or PR positive breast cancer who were
                  prescribed tamoxifen or aromatase inhibitor (AI) during the 12-month reporting period
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Copyright</span></td>
               <td width="80%" colspan="3"><pre>&copy; 2010 American Medical Association, American Society of Clinical Oncology, and National Comprehensive Cancer Network. All Rights Reserved</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure scoring</span></td>
               <td width="80%" colspan="3">Proportion</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure type</span></td>
               <td width="80%" colspan="3">Process</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Stratification</span></td>
               <td width="80%" colspan="3"><pre>None</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Risk Adjustment</span></td>
               <td width="80%" colspan="3"><pre>None</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Data Aggregation</span></td>
               <td width="80%" colspan="3"><pre></pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Rationale</span></td>
               <td width="80%" colspan="3"><pre>Despite evidence suggesting the role of adjuvant endocrine therapy in lowering the risk of tumor recurrence, many female patients who should be receiving this therapy are not. 

This measure assesses whether patients with a certain stage of breast cancer (IC through IIIC) and ER/PR+ are currently receiving the therapy. 

There are allowable medical, patient, and system reasons to document instances in which a woman with stage IC through IIIC, ER/PR+ may not be a candidate for the therapy.</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Clinical Recommendation Statement</span></td>
               <td width="80%" colspan="3"><pre>Adjuvant therapy for postmenopausal women with hormone receptor&#8211;positive breast cancer should include an aromatase inhibitor in order to lower the risk of tumor recurrence. Aromatase inhibitors are appropriate as initial treatment for women with contraindications to tamoxifen. For all other postmenopausal women, treatment options include 5 years of aromatase inhibitors treatment or sequential therapy consisting of tamoxifen (for either 2 to 3 years or 5 years) followed by aromatase inhibitors for 2 to 3, or 5 years (ASCO guidelines include narrative rankings) (ASCO). 

Patients intolerant of aromatase inhibitors should receive tamoxifen. Women with hormone receptor&#8211;negative tumors should not receive adjuvant endocrine therapy (ASCO guidelines include narrative rankings) (ASCO). 

Patients with invasive breast cancers that are estrogen or progesterone receptor positive should be considered for adjuvant endocrine therapy regardless of patient age, lymph node status, or whether or not adjuvant chemotherapy is to be administered (Category 2A) (NCCN). 

The most firmly established adjuvant endocrine therapy is tamoxifen for both premenopausal and postmenopausal women. Prospective, randomized trials demonstrate that the optimal duration of tamoxifen appears to be five years. In patients receiving both tamoxifen and chemotherapy, chemotherapy should be given first, followed by sequential tamoxifen. Several studies have evaluated aromatase inhibitors in the treatment of postmenopausal women with early-stage breast cancer (Category 2A) (NCCN).</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Improvement notation</span></td>
               <td width="80%" colspan="3"><pre>Higher score indicates better quality</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measurement duration</span></td>
               <td width="80%" colspan="3"><pre>12 month(s)</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3"><pre>Winer EP, Hudis C, Burstein HJ, et al. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. J Clin Oncol. 2005 Jan 20;23(3):619-29. Available at: http://www.asco.org.</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3"><pre>National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology: Breast Cancer. Version 1, 2007. Available at: http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf.</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3"><pre>Initial Patient Population(s): Patient Age:  Female patients aged 18 years and older at the beginning of the measurement period.
Diagnosis, Active:  Patient has a documented diagnosis of breast cancer.
Encounter:  At least 2 visits with the physician, physician&#8217;s assistant, or nurse practitioner during the measurement period.</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3"><pre>Denominator(s): All female patients aged 18 years and older with Stage IC through IIIC, estrogen receptor (ER) or progesterone receptor (PR) positive breast cancer.</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3"><pre>Denominator Exclusion(s): N/A</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3"><pre>Numerator(s): Patients who were prescribed tamoxifen or aromatase inhibitor (AI) within the 12 month reporting period.</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3"><pre>Denominator Exception(s): Documentation of medical reason(s) for not prescribing tamoxifen or aromatase inhibitor (eg, patient&#8217;s disease has progressed to metastatic, patient is receiving a gonadotropin-releasing hormone analogue, patient has received oophorectomy, patient is receiving radiation or chemotherapy, patient&#8217;s diagnosis date was &#8805; 5 years from reporting date).
Documentation of patient reason(s) for not prescribing tamoxifen or aromatase inhibitor (eg, patient refusal).
Documentation of system reason(s) for not prescribing tamoxifen or aromatase inhibitor (eg, patient is currently enrolled in a clinical trial).</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Guidance</span></td>
               <td width="80%" colspan="3"><pre>The denominator for this measure has been limited to patients with a first recorded breast cancer diagnosis within the past 5 years. The numerator captures patients who are prescribed adjuvant tamoxifen or AI, or received adjuvant tamoxifen or AI during the 12 month period. Date of breast cancer diagnosis is defined as date of pathologic diagnosis.</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Supplemental Data Elements</span></td>
               <td width="80%" colspan="3"><pre>Report "Patient Characteristic: Gender" using "Gender HL7 Value Set (2.16.840.1.113883.1.11.1)"; Report "Patient Characteristic: Race" using "Race CDC Value Set (2.16.840.1.114222.4.11.836)"; Report "Patient Characteristic: Ethnicity" using "Ethnicity CDC Value Set (2.16.840.1.114222.4.11.837)"; Report "Patient Characteristic: Payer" using "Payer Source of Payment Typology Value Set (2.16.840.1.113883.3.221.5)".</pre></td>
            </tr>
         </tbody>
      </table>
      <h2><a name="toc">Table of Contents</a></h2>
      <ul>
         <li><a href="#d56117e362">Population criteria</a></li>
         <li><a href="#d56117e3820">Data criteria (QDM Data Elements)</a></li>
         <li><a href="#d56117e4778">Supplemental Data Elements</a></li>
      </ul>
      <hr align="left" color="teal" size="2" width="80%">
      <h3><a name="d56117e362" href="#toc">Population criteria</a></h3>
      <div>
         
         <ul>
            <li>
               <b>Initial Patient Population =</b>
               
               <ul>
                  <li>AND: "Patient Characteristic: birth date"  &gt;= 18 year(s) starts before start of "Measurement period"</li>
                  <li>AND:  FIRST: "Diagnosis, Active: Breast Cancer"  &lt;= 5 year(s) starts before or during ("Encounter: Encounter Office Visit"
                     during "Measurement period")
                  </li>
                  <li>AND: Count &gt;= 2  of:"Encounter: Encounter Office Visit" during "Measurement period"</li>
               </ul>
               
            </li>
            <li>
               <b>Denominator =</b>
               
               <ul>
                  <li>AND: "Initial Patient Population"</li>
                  <li>AND: "Patient Characteristic: Gender Female"</li>
                  <li>AND: "Procedure, Result: Breast Cancer ER or PR Positive"</li>
                  <li>AND: 
                     <ul>
                        <li>OR: 
                           <ul>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Primary Tumor Size T1c')"</li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Regional Lymph Node Status
                                 N0')"
                              </li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Distant Metastasis Status M0')"</li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Primary Tumor Size T1c')"</li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Regional Lymph Node Status
                                 N1mi')"
                              </li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Distant Metastasis Status M0')"</li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Primary Tumor Size T0')"</li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Regional Lymph Node Status
                                 N1')"
                              </li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Distant Metastasis Status M0')"</li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Primary Tumor Size T1')"</li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Regional Lymph Node Status
                                 N1')"
                              </li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Distant Metastasis Status M0')"</li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Primary Tumor Size T2')"</li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Regional Lymph Node Status
                                 N0')"
                              </li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Distant Metastasis Status M0')"</li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Primary Tumor Size T2')"</li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Regional Lymph Node Status
                                 N1')"
                              </li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Distant Metastasis Status M0')"</li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Primary Tumor Size T3')"</li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Regional Lymph Node Status
                                 N0')"
                              </li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Distant Metastasis Status M0')"</li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Primary Tumor Size T0')"</li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Regional Lymph Node Status
                                 N2')"
                              </li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Distant Metastasis Status M0')"</li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Primary Tumor Size T1')"</li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Regional Lymph Node Status
                                 N2')"
                              </li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Distant Metastasis Status M0')"</li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Primary Tumor Size T2')"</li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Regional Lymph Node Status
                                 N2')"
                              </li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Distant Metastasis Status M0')"</li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Primary Tumor Size T3')"</li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Regional Lymph Node Status
                                 N1')"
                              </li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Distant Metastasis Status M0')"</li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Primary Tumor Size T3')"</li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Regional Lymph Node Status
                                 N2')"
                              </li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Distant Metastasis Status M0')"</li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Primary Tumor Size T4')"</li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Regional Lymph Node Status
                                 N0')"
                              </li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Distant Metastasis Status M0')"</li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Primary Tumor Size T4')"</li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Regional Lymph Node Status
                                 N1')"
                              </li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Distant Metastasis Status M0')"</li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Primary Tumor Size T4')"</li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Regional Lymph Node Status
                                 N2')"
                              </li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Distant Metastasis Status M0')"</li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Breast Cancer Regional Lymph Node Status
                                 N3')"
                              </li>
                              <li>AND: "Occurrence A of Procedure, Performed: Clinical Staging Procedure (result: 'Distant Metastasis Status M0')"</li>
                           </ul>
                           
                        </li>
                        <li> starts before or during  ("Encounter: Encounter Office Visit" during "Measurement period")</li>
                     </ul>
                     
                  </li>
               </ul>
               
            </li>
            <li>
               <b>Denominator Exclusions =</b>
               
               <ul>
                  <li>None</li>
               </ul>
               
            </li>
            <li>
               <b>Numerator =</b>
               
               <ul>
                  <li>AND: 
                     <ul>
                        <li>OR: "Medication, Order: Tamoxifen or Aromatase Inhibitor Therapy"</li>
                        <li>OR: "Medication, Active: Tamoxifen or Aromatase Inhibitor Therapy"</li>
                        <li> during "Measurement period"</li>
                     </ul>
                     
                  </li>
               </ul>
               
            </li>
            <li>
               <b>Denominator Exceptions =</b>
               
               <ul>
                  <li>AND: 
                     <ul>
                        <li>OR: 
                           <ul>
                              <li>OR: 
                                 <ul>
                                    <li>OR: "Medication, Order not done: System reason" for "Tamoxifen or Aromatase Inhibitor Therapy RxNorm Value Set"</li>
                                    <li>OR: "Medication, Order not done: Patient reason" for "Tamoxifen or Aromatase Inhibitor Therapy RxNorm Value Set"</li>
                                    <li>OR: "Medication, Order not done: Medical reason" for "Tamoxifen or Aromatase Inhibitor Therapy RxNorm Value Set"</li>
                                 </ul>
                                 
                              </li>
                              <li>OR: 
                                 <ul>
                                    <li>OR: "Medication, Active not done: System reason" for "Tamoxifen or Aromatase Inhibitor Therapy RxNorm Value Set"</li>
                                    <li>OR: "Medication, Active not done: Patient reason" for "Tamoxifen or Aromatase Inhibitor Therapy RxNorm Value Set"</li>
                                    <li>OR: "Medication, Active not done: Medical reason" for "Tamoxifen or Aromatase Inhibitor Therapy RxNorm Value Set"</li>
                                 </ul>
                                 
                              </li>
                              <li>OR: 
                                 <ul>
                                    <li>OR: "Medication, Intolerance: Tamoxifen or Aromatase Inhibitor Therapy"</li>
                                    <li>OR: "Medication, Adverse Effects: Tamoxifen or Aromatase Inhibitor Therapy"</li>
                                    <li>OR: "Medication, Allergy: Tamoxifen or Aromatase Inhibitor Therapy"</li>
                                    <li>OR: "Medication, Active: Gonadotropin-releasing hormone analogue medication"</li>
                                    <li>OR: "Procedure, Performed: Bilateral Oophorectomy"</li>
                                    <li>OR: "Diagnosis, Active: Metastatic Sites Common to Breast Cancer"</li>
                                 </ul>
                                 
                              </li>
                              <li> starts before or during  ("Encounter: Encounter Office Visit" during "Measurement period")</li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>OR: "Procedure, Performed: Radiation Therapy"</li>
                              <li>OR: "Procedure, Performed: Chemotherapy"</li>
                              <li> during "Measurement period"</li>
                           </ul>
                           
                        </li>
                     </ul>
                     
                  </li>
               </ul>
               
            </li>
         </ul>
         
      </div>
      <h3><a name="d56117e3820" href="#toc">Data criteria (QDM Data Elements)</a></h3>
      <div>
         
         <ul>
            <li>
               "Diagnosis, Active: Breast Cancer" using "Breast Cancer Value Set GROUPING (2.16.840.1.113883.3.526.03.389)"
            </li>
            <li>
               "Diagnosis, Active: Metastatic Sites Common to Breast Cancer" using "Metastatic Sites Common to Breast Cancer Value Set GROUPING (2.16.840.1.113883.3.526.03.447)"
            </li>
            <li>
               "Encounter: Encounter Office Visit" using "Encounter Office Visit CPT Value Set (2.16.840.1.113883.3.526.02.114)"
            </li>
            <li>
               "Medication, Active: Gonadotropin-releasing hormone analogue medication" using "Gonadotropin-releasing hormone analogue medication Value Set (2.16.840.1.113883.3.526.02.467)"
            </li>
            <li>
               "Medication, Active: Tamoxifen or Aromatase Inhibitor Therapy" using "Tamoxifen or Aromatase Inhibitor Therapy RxNorm Value Set (2.16.840.1.113883.3.526.02.285)"
            </li>
            <li>
               "Medication, Active not done: Medical reason" using "Medical reason SNOMED-CT Value Set (2.16.840.1.113883.3.526.02.313)"
            </li>
            <li>
               "Medication, Active not done: Patient reason" using "Patient reason SNOMED-CT Value Set (2.16.840.1.113883.3.526.02.311)"
            </li>
            <li>
               "Medication, Active not done: System reason" using "System reason SNOMED-CT Value Set (2.16.840.1.113883.3.526.02.310)"
            </li>
            <li>
               "Medication, Adverse Effects: Tamoxifen or Aromatase Inhibitor Therapy" using "Tamoxifen or Aromatase Inhibitor Therapy RxNorm Value Set (2.16.840.1.113883.3.526.02.285)"
            </li>
            <li>
               "Medication, Allergy: Tamoxifen or Aromatase Inhibitor Therapy" using "Tamoxifen or Aromatase Inhibitor Therapy RxNorm Value Set (2.16.840.1.113883.3.526.02.285)"
            </li>
            <li>
               "Medication, Intolerance: Tamoxifen or Aromatase Inhibitor Therapy" using "Tamoxifen or Aromatase Inhibitor Therapy RxNorm Value Set (2.16.840.1.113883.3.526.02.285)"
            </li>
            <li>
               "Medication, Order: Tamoxifen or Aromatase Inhibitor Therapy" using "Tamoxifen or Aromatase Inhibitor Therapy RxNorm Value Set (2.16.840.1.113883.3.526.02.285)"
            </li>
            <li>
               "Medication, Order not done: Medical reason" using "Medical reason SNOMED-CT Value Set (2.16.840.1.113883.3.526.02.313)"
            </li>
            <li>
               "Medication, Order not done: Patient reason" using "Patient reason SNOMED-CT Value Set (2.16.840.1.113883.3.526.02.311)"
            </li>
            <li>
               "Medication, Order not done: System reason" using "System reason SNOMED-CT Value Set (2.16.840.1.113883.3.526.02.310)"
            </li>
            <li>
               "Patient Characteristic: birth date" using "birth date LOINC Value Set (2.16.840.1.113883.3.560.100.4)"
            </li>
            <li>
               "Patient Characteristic: Gender Female" using "Gender Female HL7 Value Set (2.16.840.1.113883.1.11.1)"
            </li>
            <li>
               "Procedure, Performed: Bilateral Oophorectomy" using "Bilateral Oophorectomy Value Set GROUPING (2.16.840.1.113883.3.526.03.471)"
            </li>
            <li>
               "Procedure, Performed: Chemotherapy" using "Chemotherapy Value Set GROUPING (2.16.840.1.113883.3.526.03.485)"
            </li>
            <li>
               "Procedure, Performed: Clinical Staging Procedure" using "Clinical Staging Procedure SNOMED-CT Value Set (2.16.840.1.113883.3.526.02.1027)"
            </li>
            <li>
               "Procedure, Performed: Radiation Therapy" using "Radiation Therapy Value Set GROUPING (2.16.840.1.113883.3.526.03.482)"
            </li>
            <li>
               "Procedure, Result: Breast Cancer ER or PR Positive" using "Breast Cancer ER or PR Positive SNOMED-CT Value Set (2.16.840.1.113883.3.526.02.284)"
            </li>
            <li>
               Attribute: "Result: Breast Cancer Primary Tumor Size T0" using "Breast Cancer Primary Tumor Size T0 SNOMED-CT Value Set  (2.16.840.1.113883.3.526.02.1013)"
            </li>
            <li>
               Attribute: "Result: Breast Cancer Primary Tumor Size T1c" using "Breast Cancer Primary Tumor Size T1c SNOMED-CT Value Set  (2.16.840.1.113883.3.526.02.1014)"
            </li>
            <li>
               Attribute: "Result: Breast Cancer Primary Tumor Size T1" using "Breast Cancer Primary Tumor Size T1 SNOMED-CT Value Set  (2.16.840.1.113883.3.526.02.1015)"
            </li>
            <li>
               Attribute: "Result: Breast Cancer Primary Tumor Size T2" using "Breast Cancer Primary Tumor Size T2 SNOMED-CT Value Set  (2.16.840.1.113883.3.526.02.1016)"
            </li>
            <li>
               Attribute: "Result: Breast Cancer Primary Tumor Size T3" using "Breast Cancer Primary Tumor Size T3 SNOMED-CT Value Set  (2.16.840.1.113883.3.526.02.1017)"
            </li>
            <li>
               Attribute: "Result: Breast Cancer Primary Tumor Size T4" using "Breast Cancer Primary Tumor Size T4 SNOMED-CT Value Set  (2.16.840.1.113883.3.526.02.1018)"
            </li>
            <li>
               Attribute: "Result: Breast Cancer Regional Lymph Node Status N0" using "Breast Cancer Regional Lymph Node Status N0 SNOMED-CT Value Set  (2.16.840.1.113883.3.526.02.1019)"
            </li>
            <li>
               Attribute: "Result: Breast Cancer Regional Lymph Node Status N1mi" using "Breast Cancer Regional Lymph Node Status N1mi SNOMED-CT Value Set  (2.16.840.1.113883.3.526.02.1020)"
            </li>
            <li>
               Attribute: "Result: Breast Cancer Regional Lymph Node Status N1" using "Breast Cancer Regional Lymph Node Status N1 SNOMED-CT Value Set  (2.16.840.1.113883.3.526.02.1021)"
            </li>
            <li>
               Attribute: "Result: Breast Cancer Regional Lymph Node Status N2" using "Breast Cancer Regional Lymph Node Status N2 SNOMED-CT Value Set  (2.16.840.1.113883.3.526.02.1022)"
            </li>
            <li>
               Attribute: "Result: Breast Cancer Regional Lymph Node Status N3" using "Breast Cancer Regional Lymph Node Status N3 SNOMED-CT Value Set  (2.16.840.1.113883.3.526.02.1028)"
            </li>
            <li>
               Attribute: "Result: Distant Metastasis Status M0" using "Distant Metastasis Status M0 SNOMED-CT Value Set  (2.16.840.1.113883.3.526.02.1012)"
            </li>
         </ul>
         
      </div>
      <h3><a name="d56117e4778" href="#toc">Supplemental Data Elements</a></h3>
      <div>
         
         <ul>
            <li>"Patient Characteristic: Gender" using "Gender HL7 Value Set (2.16.840.1.113883.1.11.1)"</li>
            <li>"Patient Characteristic: Race" using "Race CDC Value Set (2.16.840.1.114222.4.11.836)"</li>
            <li>"Patient Characteristic: Ethnicity" using "Ethnicity CDC Value Set (2.16.840.1.114222.4.11.837)"</li>
            <li>"Patient Characteristic: Payer" using "Payer Source of Payment Typology Value Set (2.16.840.1.113883.3.221.5)"</li>
         </ul>
         
      </div><br><hr align="left" color="teal" size="2" width="80%"><br><table class="header_table">
         <tbody>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure set</span></td>
               <td colspan="3">CLINICAL QUALITY MEASURE SET 2011-2012</td>
            </tr>
         </tbody>
      </table>
   </body>
</html>